STING1 and cancer: This study demonstrates that STING may be upregulated in the mPFC and may contribute to cancer-induced bone pain in rats, whereas, therapeutic administration using the STING antagonist C-176 inhibits STING-induced central neuroinflammation and M1 type polarization of microglia.